CN109369559A - Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method - Google Patents

Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method Download PDF

Info

Publication number
CN109369559A
CN109369559A CN201811341550.4A CN201811341550A CN109369559A CN 109369559 A CN109369559 A CN 109369559A CN 201811341550 A CN201811341550 A CN 201811341550A CN 109369559 A CN109369559 A CN 109369559A
Authority
CN
China
Prior art keywords
xenyl
oxadiazoles
dmf
carbon source
oxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811341550.4A
Other languages
Chinese (zh)
Inventor
及方华
王守才
蒋光彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guilin University of Technology
Original Assignee
Guilin University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilin University of Technology filed Critical Guilin University of Technology
Priority to CN201811341550.4A priority Critical patent/CN109369559A/en
Publication of CN109369559A publication Critical patent/CN109369559A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses one kind with DMF(N, dinethylformamide) be one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method.This method is using 4- biphenyl carboxylic acid hydrazine as reaction raw materials, with DMF(N, dinethylformamide) it is used as carbon source through carbon cyclization, a step constructs 2-(4- xenyl) -1,3,4- oxadiazoles.The method of the present invention synthesizing mean is novel, and reaction condition is mild, meets the demand for development of Green Chemistry.

Description

Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method
Technical field
The invention belongs to the technical fields such as medicine, material, cell biology, and in particular to DMF(N, N- dimethyl methyl Amide) be one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method.
Background technique
1,3,4- oxadiazoles and its derivative are a kind of important physiological activators, have certain anti-inflammatory, antibacterial, resist Cancer, anti-AIDS and coordinate plant growth isoreactivity, certain 1,3,4- furodiazole compounds are also important photoactive substance, have Optical activity can be used as photosensitive macromolecular material applied to electroluminescence instrument.The drug for hypertension tiodazosin listed With the structural unit in Nesapidil all containing 1,3,4- oxadiazoles.Therefore, to the synthesis one of 1,3,4- furodiazole compound It has all been the research hotspot of chemist since straight.Its traditional synthetic method will often use toxic chemical reagent, such as trichlorine oxygen Phosphorus etc..The present invention is with DMF(N, dinethylformamide) it is carbon source, using 4- biphenyl carboxylic acid hydrazine as reaction raw materials, mild Reaction condition constructs 2-(4- xenyl in next step) -1,3,4- oxadiazoles.
The 2-(4- xenyl that the present invention synthesizes) -1,3,4- oxadiazoles, structural formula is as follows:
With DMF(N, dinethylformamide) be that one step of carbon source constructs 2-(4- xenyl) -1, the method for 3,4- oxadiazoles, New synthesis path is provided for the synthesis of such compound, because of its simple synthetic line, there is huge application value.
Summary of the invention
The object of the present invention is to provide one kind with DMF(N, dinethylformamide) it is that one step of carbon source constructs 2-(4- biphenyl Base) -1,3,4- oxadiazoles method.
Specific steps are as follows:
Raw material is weighed according to following molar ratio, catalyst: oxidant: 4- biphenyl carboxylic acid hydrazine=0.05 ~ 0.5:1 ~ 4:1;It will claim The raw material taken is placed in reaction vessel, is added solvent n,N-Dimethylformamide (DMF), and carbocyclic ring is carried out at 40 ~ 150 DEG C Reaction 1 ~ 72 hour;Products therefrom is isolated and purified using column chromatography, and column chromatographic eluate is the mixed of petroleum ether and ethyl acetate Liquid is closed, wherein the volume ratio of petroleum ether and ethyl acetate is 1 ~ 40:1, after isolating and purifying, obtains 2-(4- xenyl) -1,3, 4- oxadiazoles.
The catalyst is cuprous iodide.
The oxidant is potassium peroxydisulfate.
The method of the present invention has the advantage that
(1) reaction condition is mild.
(2) reaction raw materials are simple and easy to get, green safe.
(3) synthetic route is novel.
Detailed description of the invention
Fig. 1 is the synthetic route chart of the method for the present invention.
Fig. 2 be the embodiment of the present invention 1 obtained in 2-(4- xenyl) -1,3,4- oxadiazoles nuclear magnetic resonance spectroscopy.
Fig. 3 be the embodiment of the present invention 1 obtained in 2-(4- xenyl) -1,3,4- oxadiazoles carbon-13 nmr spectra.
Specific embodiment
The invention is further described below by specific embodiment.
Embodiment 1:
0.2 mM of the 4- biphenyl carboxylic acid hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, potassium peroxydisulfate 0.2 MM, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred at 120 DEG C.TLC(thin-layered chromatography) detection is instead Reaction solution is cooled to room temperature, reaction solution filtering, extraction, filtrate decompression revolving removal solvent after answering, then is chromatographed by column Isolate and purify, obtain target product 2-(4- xenyl) -1,3,4- oxadiazoles, it is 3 that column chromatographic eluate used, which is volume ratio: 1 petroleum ether: ethyl acetate mixtures, yield 60%.
The present embodiment structure of title compound is shown in Fig. 2 and Fig. 3.
Comparative example 1:
0.2 mM of the 4- biphenyl carboxylic acid hydrazine of addition in the test tube of 25 mL, 0.05 mM of cuprous iodide, t-butyl peroxy Change 0.2 mM of hydrogen, DMF(N, dinethylformamide be added) it is used as solvent, it is stirred at 120 DEG C.TLC(thin-layer chromatography Method) tracing detection, do not detect target product.
Comparative example 2:
0.2 mM of 4- biphenyl carboxylic acid hydrazine is added in the test tube of 25 mL, 0.05 mM of cuprous iodide, silver carbonate 0.2 is in the least Mole, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking Detection, does not detect target product.
Comparative example 3:
0.2 mM of 4- biphenyl carboxylic acid hydrazine is added in the test tube of 25 mL, 0.05 mM of cuprous iodide, silver nitrate 0.2 is in the least Mole, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking Detection, does not detect target product.
Comparative example 4:
0.2 mM of 4- biphenyl carboxylic acid hydrazine is added in the test tube of 25 mL, 0.05 mM of cuprous iodide, silver oxide 0.2 is in the least Mole, DMF(N, dinethylformamide is added) it is used as solvent, it is stirred under 120 degrees Celsius.TLC(thin-layered chromatography) tracking Detection, does not detect target product.
In above-described embodiment, oxidant species have a significant impact reaction effect, and concrete outcome is shown in Table 1.
Table 1
Example Oxidant(oxidant) Yield (%)
Embodiment 1 Potassium peroxydisulfate 60
Comparative example 1 Tert-butyl hydroperoxide 0
Comparative example 2 Silver carbonate 0
Comparative example 3 Silver nitrate 0
Comparative example 4 Silver oxide 0
The present invention has apparent oxidant specificity, can just detect when only using potassium peroxydisulfate as oxidant accordingly Target product;In addition to this, reaction raw materials of the invention are 4- biphenyl carboxylic acid hydrazine, and raw material is simple and easy to get, and the target of generation produces Object 1,3,4- oxadiazoles are then the star molecules of drug field, which is that the synthesis of 1,3,4- furodiazole compounds mentions New Research Thinking is supplied.

Claims (1)

1. a kind of construct 2-(4- xenyl by one step of carbon source of DMF) -1, the method for 3,4- oxadiazoles, it is characterised in that specific step Suddenly are as follows:
Raw material is weighed according to following molar ratio, catalyst: oxidant: 4- biphenyl carboxylic acid hydrazine=0.05 ~ 0.5:1 ~ 4:1;It will weigh Raw material be placed in reaction vessel, be added solvent n,N-Dimethylformamide, at 40 ~ 150 DEG C carry out carbon cyclization 1 ~ 72 Hour;Products therefrom is isolated and purified using column chromatography, and column chromatographic eluate is the mixed liquor of petroleum ether and ethyl acetate, wherein The volume ratio of petroleum ether and ethyl acetate is 1 ~ 40:1, after isolating and purifying, obtains 2-(4- xenyl) -1,3,4- oxadiazoles;
The catalyst is cuprous iodide;
The oxidant is potassium peroxydisulfate.
CN201811341550.4A 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method Withdrawn CN109369559A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811341550.4A CN109369559A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811341550.4A CN109369559A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method

Publications (1)

Publication Number Publication Date
CN109369559A true CN109369559A (en) 2019-02-22

Family

ID=65384799

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811341550.4A Withdrawn CN109369559A (en) 2018-11-12 2018-11-12 Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method

Country Status (1)

Country Link
CN (1) CN109369559A (en)

Similar Documents

Publication Publication Date Title
Pinto et al. Bismuth (III) salts mediated regioselective ring opening of epoxides: an easy route to halohydrins and β-hydroxy nitrates
CN109627193B (en) Diaryl azo oxygen compound with anti-tumor effect and synthesis method thereof
CN109369559A (en) Using DMF as one step of carbon source construct 2-(4- xenyl) -1,3,4- oxadiazoles method
CN106397381B (en) 2- alkoxy chromone 9 oxime derivate and the preparation method and application thereof
CN106831435A (en) A kind of preparation method of the naphthol derivative of 1 nitro 2
CN109336839A (en) Using DMF as one step of carbon source construct 2-(3- tolyl) -1,3,4- oxadiazoles method
CN109232461A (en) Using DMF as one step of carbon source construct 2-(2- tolyl) -1,3,4- oxadiazoles method
CN109336837A (en) Using DMF as one step of carbon source construct 2-(4- cyano-phenyl) -1,3,4- oxadiazoles method
CN108191919B (en) - 2 (1H) -one of 4- (substituted-phenyl) -6- ferrocenyl -3,4- dihydro-pyrimidin and preparation method thereof
CN109336841A (en) Using DMF as one step of carbon source construct 2-(4- nitrobenzophenone) -1,3,4- oxadiazoles method
CN109336838A (en) The method for constructing 2- p-methylphenyl -1,3,4- oxadiazoles as one step of carbon source using DMF
CN109369560A (en) Using DMF as one step of carbon source construct 2-(3- chlorphenyl) -1,3,4- oxadiazoles method
CN109369561A (en) Using DMF as one step of carbon source construct 2-(4- chlorphenyl) -1,3,4- oxadiazoles method
CN109206418A (en) Using DMF as one step of carbon source construct 2-(2- furyl) -1,3,4- oxadiazoles method
CN109232463A (en) Using DMF as one step of carbon source construct 2-(4- bromophenyl) -1,3,4- oxadiazoles method
CN109336840A (en) Using DMF as one step of carbon source construct 2-(4- fluorophenyl) -1,3,4- oxadiazoles method
CN109251185A (en) The method for constructing 2- phenyl -1,3,4- oxadiazoles as one step of carbon source using DMF
CN109293650A (en) Using DMF as one step of carbon source construct 2-(2- thienyl) -1,3,4- oxadiazoles method
CN109232462A (en) Using DMF as one step of carbon source construct 2-(1- naphthalene) -1,3,4- oxadiazoles method
CN109206382A (en) Using DMF as one step of carbon source construct 2-(4- tert-butyl-phenyl) -1,3,4- oxadiazoles method
CN109160905A (en) Using DMF as one step of carbon source construct 2-(4- trifluoromethyl) -1,3,4- oxadiazoles method
CN109293594A (en) Using DMF as one step of carbon source construct 2-(4- methoxyphenyl) -1,3,4- oxadiazoles method
CN109336880A (en) 2-(3,4- methylenedioxyphenyl are constructed by one step of carbon source of DMF) -1, the method for 3,4- oxadiazoles
CN113072520A (en) C2 substituted 2H-benzothiazole aryl acylation derivative and synthesis method and application thereof
CN111635401A (en) Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190222